DiagnosingDx

1:21

Infectious Disease Dx Is 10 Years Behind Cancer – Brad Murray #HealthTech #InfectiousDisease

1:24

Boosting Dx Yield Beyond Standard of Care – Brad Murray #Diagnostics #InfectiousDisease #HealthTech

0:42

From “Do You Have X?” to “What’s There?” – Delve’s New Dx Approach #Diagnostics #InfectiousDisease

2:20

Why Execution Beats Vision in Biotech – Brad Murray #Biotech #Diagnostics #StartupLife

44:36

From Hypothesis-Driven to Hypothesis-Free: The Future of Dx with Brad Murray

2:38

From Hand-Coding to AI Assistants: How GenAI Transforms Statistics – Tara Maddala #AIinHealthcare

1:02

3 Things Every Startup Must Get Right – Tara Maddala #Startups #Diagnostics #HealthcareInnovation

2:22

Hope is Not a Strategy in Diagnostics 🚫🔬 #diagnostics #healthtech #podcastclips

48:53

Truth-Seeking in Diagnostics: Lessons from Genomic Health to Mental Health - Tara Maddala

1:54

From Personal Loss to Genomic Innovation | Tara Maddala on Her Why

1:21

Reimbursement Pays the Bills in Healthcare #MedTech #Diagnostics #StartupStrategy

0:57

Cool Tech Won’t Win Without This in Healthcare #MedTech #Diagnostics #HealthcareInnovation

0:32

Why Owning a Small Market Can Beat Chasing a Big One #StartupStrategy #Diagnostics #Healthcare

55:50

From Science to Sales — The Hard Truths of Commercializing Diagnostics Today - Mark Oldroyd

1:48

Who Owns Your Health Data? It Might Not Be You – Dr. James Kelley #HealthData #AIinHealthcare #Dx

1:03

From 1 Day to 20 Minutes: How Virtual Staining Speeds Dx – James Kelley #Pathology #Diagnostics

1:03

AI Won’t Replace You—But Professionals Who Use It Will #AIinHealthcare #HealthTech #Diagnostics

39:56

AI, Virtual Staining & the Future of Pathology – James Kelley

2:10

Why Top Oncologists Prefer Liquid Biopsy Over the Gold Standard – Vincent Funari #MedTech #Podcast

1:37

From 1K to 50K Tests a Day: NeoGenomics' COVID Pivot – Vincent Funari #COVID19 #Diagnostics #Health

1:13

FDA Called It the Best Heme Assay They’d Seen – Vincent Funari #Diagnostics #FDA #CancerDiagnostics

47:35

Building Assays, Battling COVID on the Frontline, and What’s Next in Dx – Vincent Funari

2:21

FDA or LDT? Why Regulatory Strategy Starts With Your Business Model – Mort Minaee #Diagnostics #FDA

40:52

LDT's safe for now, but for how long? What startups must know – Mort Minaee

0:53

25+ Markers in One Test? How PictorDx Is Multiplexing Fast #Proteomics #Diagnostics #MedTech

1:11

Proteomics Feels Like Genomics 20 Years Ago – Janine McMurdie #Proteomics #Diagnostics #HealthTech

49:16

How Pictor Is Scaling Proteomics for Faster, Smarter Testing – Janine McMurdie

1:10

Alzheimer’s Dx Is Failing Millions – Dr. Sam Agus on Fixing the System #Alzheimers #Diagnostics

2:19

Defining ‘Early’ in Chronic Disease Dx – Prognostics Matter #Prognostics #MedTech #Diagnostics

1:32

Peace of Mind Matters in Dx Too – Investors Take Note #Diagnostics #HealthcareInnovation #Podcast

56:07

Developing Biomarker strategies and the future of Prognostics - Sam Agus

0:54

Why Fundraising Is So Tough in Molecular Dx Right Now – Kim Langone #startups #healthtech #podcast

1:05

The Culture That Built a Breakthrough – Kim Langone on Genomic Health #healthtech #podcast #startup

56:18

MDx innovation and culture and the future of diagnostics R&D – Kim Langone

0:59

Huge FDA Mistake Startups Keep Making – Heinz Steneberg 💡 #startupmistakes #fda #scienceshorts

0:59

Regulatory Strategy for Startups in Dx – with Heinz Steneberg 📝 #regulatory #healthtech #startups

51:58

Regulatory strategy for startups in Dx and mistakes to avoid – Heinz Steneberg